Angioplasty, Balloon, Coronary ; Hospital Communication Systems ; organization & administration ; Humans ; Interdisciplinary Communication ; Myocardial Infarction ; therapy ; Patient Care Team ; Patient Transfer ; Time Factors

Angioplasty, Balloon, Coronary ; Coronary Restenosis ; Humans ; Practice Guidelines as Topic

Angioplasty, Balloon, Coronary ; Clinical Trials as Topic ; Humans ; Myocardial Infarction ; drug therapy ; therapy ; Practice Guidelines as Topic

Biomarkers ; Electrocardiography ; Humans ; Myocardial Infarction

Angioplasty, Balloon, Coronary ; methods ; Coronary Disease ; therapy ; Coronary Thrombosis ; etiology ; Drug Delivery Systems ; Humans ; Paclitaxel ; administration & dosage ; Sirolimus ; administration & dosage ; Stents ; adverse effects

Angioplasty, Balloon, Coronary ; Coronary Artery Bypass ; Coronary Disease ; therapy ; Guideline Adherence ; Humans ; Practice Guidelines as Topic

Angioplasty, Balloon, Coronary ; Coronary Disease ; therapy ; Humans ; Stents

Angioplasty, Balloon, Coronary ; instrumentation ; Drug Delivery Systems ; instrumentation ; Equipment Safety ; Follow-Up Studies ; Humans ; Stents

Humans ; Myocardial Infarction ; physiopathology ; therapy ; Practice Guidelines as Topic

Low-dose chemotherapy is concerned in treating malignant tumor in recent years.The lowdose,metronomic chemotherapy is not only effective in antiangiogenic,but also avoid chemotherapy side effects,such as suppression of bone marrow,dysfunction of liver and kidney,gastrointestinal reaction and drug resistance.Thereby it can increase patient compliance,improve life quality and prolong survival time.Currently chemotherapy in neuroblastoma still plays a key role,especially low-dose chemotherapy,which can protect self-immune function and reduce the physical injury in children.